The Procter & Gamble Company
- What it sells
- Fabric & Home Care is 35% and Baby, Feminine & Family Care 23% of revenue (fiscal year to Jun 2026), from 35% and 24% two years earlier.
- Growing?
- Yes: revenue up 4% on a year earlier (quarter ended Sep 2026); earnings per share down 3% over the last four quarters.
- Expensive?
- About usual: 25.3× trailing earnings; its five-year median is 25.5×. Priced 26% below the peer median of 34.3x.
- Analysts?
- 56% of 25 say buy; average 12-month target $174, 4% above today's price.
- Risky?
- About average for a large company: its price swung 21% over the past year (the S&P 500's 14%), and it fell as much as 25% since Nov 2021.
The Procter & Gamble Company (P&G) is a global branded consumer packaged goods company that sells daily-use products across Fabric & Home Care, Baby/Feminine/Family Care, Beauty, Grooming, and Health Care, generating revenue primarily from consumer product sales through retail and e-commerce channels.
More about The Procter & Gamble Company
Its portfolio includes major brands such as Tide, Pampers, Gillette, Crest/Oral-B, and Pantene/Olay, with pricing typically set per unit (pack/bottle) and supported by merchandising and trade programs.
Market Position
P&G holds leading positions in multiple categories, including global leadership in fabric care (noted as >35% global share in fabric care behind Tide/Ariel/Downy) and leadership in blades & razors (noted as >60% global share behind Gillette/Venus). Its differentiation is driven by brand scale, sustained innovation/R&D, and global distribution across mass, club, drug, and online retailers.
Key Segments
P&G reports five primary segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
How has the stock done?
Over the past month PG rose 9.7%; the consumer staples ETF (XLP) rose 7.9% and the S&P 500 fell 2.7%.
Over the past six months PG rose 16.8%; the consumer staples ETF (XLP) rose 7.8% and the S&P 500 rose 2.6%.
Over the past year PG rose 13.5%; the consumer staples ETF (XLP) rose 17.8% and the S&P 500 rose 10.8%.
Over five years PG rose 14.6%; the consumer staples ETF (XLP) rose 25.0% and the S&P 500 rose 62.0%.
From Jan 5, 2022 to Oct 10, 2022, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 0.0% the other way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Oct 22, 2026 | ended Sep 2026 | $23.3B (+4% vs a year earlier) | $2.00 vs $1.89 (beat) | +2.7% | +2.4% |
| Jul 29, 2026 | ended Jun 2026 | $21.2B (+2% vs a year earlier) | $1.43 vs $1.41 (beat) | −3.3% | −1.4% |
| Apr 24, 2026 | ended Mar 2026 | $21.2B (+7% vs a year earlier) | $1.59 vs $1.56 (beat) | +1.8% | +1.1% |
| Jan 22, 2026 | ended Dec 2025 | $22.2B (+1% vs a year earlier) | $1.88 vs $1.86 (beat) | +2.8% | +2.6% |
| Oct 24, 2025 | ended Sep 2025 | $22.4B (+3% vs a year earlier) | — | −0.3% | −1.2% |
| Jul 29, 2025 | ended Jun 2025 | $20.9B (+2% vs a year earlier) | — | −2.7% | −4.2% |
| Apr 24, 2025 | ended Mar 2025 | $19.8B (−2% vs a year earlier) | — | −2.8% | −3.5% |
| Jan 22, 2025 | ended Dec 2024 | $21.9B (+2% vs a year earlier) | — | +2.7% | +2.8% |
| Oct 18, 2024 | ended Sep 2024 | $21.7B (−1% vs a year earlier) | — | −1.6% | −2.4% |
| Jul 30, 2024 | ended Jun 2024 | $20.5B (0% vs a year earlier) | — | −5.4% | −1.1% |
| Apr 19, 2024 | ended Mar 2024 | $20.2B (+1% vs a year earlier) | — | +2.1% | +2.5% |
| Jan 23, 2024 | ended Dec 2023 | $21.4B (+3% vs a year earlier) | — | +2.9% | +6.5% |
| Oct 18, 2023 | ended Sep 2023 | $21.9B (+6% vs a year earlier) | — | +1.4% | +3.0% |
| Jul 28, 2023 | ended Jun 2023 | $20.6B (+5% vs a year earlier) | — | +2.8% | +2.1% |
| Apr 21, 2023 | ended Mar 2023 | $20.1B (+4% vs a year earlier) | — | +3.6% | +3.7% |
| Jan 19, 2023 | ended Dec 2022 | $20.8B (−1% vs a year earlier) | — | −2.3% | −3.6% |
| Oct 19, 2022 | ended Sep 2022 | $20.6B (+1% vs a year earlier) | — | −1.1% | +2.7% |
| Jul 29, 2022 | ended Jun 2022 | $19.5B (+3% vs a year earlier) | — | −3.5% | −2.3% |
| Apr 20, 2022 | ended Mar 2022 | $19.4B (+7% vs a year earlier) | — | +2.0% | 0.0% |
| Jan 19, 2022 | ended Dec 2021 | $21.0B (+6% vs a year earlier) | — | +3.4% | +0.9% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $23.3B in the quarter ended Sep 2026, up 4% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $20.8B | −1% |
| Mar 2023 | $20.1B | +4% |
| Jun 2023 | $20.6B | +5% |
| Sep 2023 | $21.9B | +6% |
| Dec 2023 | $21.4B | +3% |
| Mar 2024 | $20.2B | +1% |
| Jun 2024 | $20.5B | 0% |
| Sep 2024 | $21.7B | −1% |
| Dec 2024 | $21.9B | +2% |
| Mar 2025 | $19.8B | −2% |
| Jun 2025 | $20.9B | +2% |
| Sep 2025 | $22.4B | +3% |
| Dec 2025 | $22.2B | +1% |
| Mar 2026 | $21.2B | +7% |
| Jun 2026 | $21.2B | +2% |
| Sep 2026 | $23.3B | +4% |
Revenue went from $82.0B in FY23 to $87.0B in FY26; net income from $14.7B to $16.0B.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY23 | $82.0B | $14.7B |
| FY24 | $84.0B | $14.9B |
| FY25 | $84.3B | $16.0B |
| FY26 | $87.0B | $16.0B |
In the fiscal year to Jun 2026, Fabric & Home Care was 35% and Baby, Feminine & Family Care was 23% of revenue.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2024 | Fabric & Home Care | $29.5B | 35% |
| FY2024 | Baby, Feminine & Family Care | $20.3B | 24% |
| FY2024 | Beauty | $15.2B | 18% |
| FY2024 | Health Care | $11.8B | 14% |
| FY2024 | Grooming | $6.7B | 8% |
| FY2024 | Other | $600M | 1% |
| FY2025 | Fabric & Home Care | $29.6B | 35% |
| FY2025 | Baby, Feminine & Family Care | $20.2B | 24% |
| FY2025 | Beauty | $15.0B | 18% |
| FY2025 | Health Care | $12.0B | 14% |
| FY2025 | Grooming | $6.7B | 8% |
| FY2025 | Other | $795M | 1% |
| FY2026 | Fabric & Home Care | $30.3B | 35% |
| FY2026 | Baby, Feminine & Family Care | $20.4B | 23% |
| FY2026 | Beauty | $16.0B | 18% |
| FY2026 | Health Care | $12.5B | 14% |
| FY2026 | Grooming | $6.9B | 8% |
| FY2026 | Other | $920M | 1% |
A year earlier $1.95
Diluted, from SEC filings
Quarters: The Procter & Gamble Company's SEC filings, named by the month they end. Fiscal years: The Procter & Gamble Company's annual reports to the SEC.
How it makes money
Of every $100 in revenue, $18.4 ends up as net income. Net margin was roughly flat over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 47.5% | 23.0% | 18.9% |
| Mar 2023 | 48.2% | 21.2% | 16.9% |
| Jun 2023 | 48.4% | 20.3% | 16.5% |
| Sep 2023 | 52.0% | 26.4% | 20.7% |
| Dec 2023 | 52.7% | 20.7% | 16.2% |
| Mar 2024 | 51.2% | 22.1% | 18.6% |
| Jun 2024 | 49.6% | 18.9% | 15.3% |
| Sep 2024 | 52.1% | 26.7% | 18.2% |
| Dec 2024 | 52.4% | 26.2% | 21.2% |
| Mar 2025 | 51.0% | 23.0% | 19.1% |
| Jun 2025 | 49.1% | 20.8% | 17.3% |
| Sep 2025 | 51.4% | 26.2% | 21.2% |
| Dec 2025 | 51.2% | 24.2% | 19.4% |
| Mar 2026 | 49.5% | 21.5% | 18.5% |
| Jun 2026 | 48.5% | 18.6% | 14.4% |
| Sep 2026 | 49.8% | 25.5% | 20.3% |
+2.3 pts over 3 years
+0.6 pts over 3 years
+0.6 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: The Procter & Gamble Company's annual reports to the SEC; quarters: SEC filings.
Customers and suppliers
In its latest annual report The Procter & Gamble Company sells to Walmart; it names no suppliers.
PGThe Procter & Gamble CompanyCustomers
The Procter & Gamble Company's 10-K for the year to Jun 2026 gives one customer's share of its revenue: Walmart Inc. And Affiliates (16%).
Show the filings' numbers
| Period | Customer | Share of revenue | Filing |
|---|---|---|---|
| Year ended Jun 2024 | Walmart Inc. And Affiliates | 16% | 10-K filed Aug 4, 2026 |
| Year ended Jun 2025 | Walmart Inc. And Affiliates | 16% | 10-K filed Aug 4, 2026 |
| Year ended Jun 2026 | Walmart Inc. And Affiliates | 16% | 10-K filed Aug 4, 2026 |
From The Procter & Gamble Company's 10-Q and 10-K filings (XBRL): each customer whose share of revenue a filing tags, under the filing's own label, so “Customer A” in one filing can be another company in the next; a later filing's figures for a period replace an earlier one's.
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| Walmart | customer | “Our largest customer, Walmart Inc. and its affiliates, accounted for consolidated net sales of approximately 16% in 2026, 2025 and 2024.” |
Only the companies The Procter & Gamble Company names in its 10-K filed Aug 4, 2026 (SEC). The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words.
Is it expensive?
P/E of 25.3x, below the peer median of 34.3x, with earnings still growing.
Priced 26% below the peer median of 34.3x.
Show the data
| Company | P/E (trailing) |
|---|---|
| EL · The Estée Lauder Companies Inc. | 111× |
| CL · Colgate-Palmolive Company | 38.2× |
| CHD · Church & Dwight Co., Inc. | 34.3× |
| PG · The Procter & Gamble Company | 25.3× |
| KVUE · Kenvue Inc | 21.9× |
| KMB · Kimberly-Clark Corporation | 10.8× |
At 25.3× trailing earnings PG is inside the middle of its five-year range; the five-year median is 25.5×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 26.5× |
| Feb 8, 2022 | 28.3× |
| May 10, 2022 | 27.0× |
| Aug 10, 2022 | 25.1× |
| Nov 8, 2022 | 23.7× |
| Feb 9, 2023 | 24.0× |
| May 11, 2023 | 26.9× |
| Aug 11, 2023 | 26.6× |
| Nov 9, 2023 | 24.4× |
| Feb 12, 2024 | 26.3× |
| May 13, 2024 | 27.1× |
| Aug 13, 2024 | 27.8× |
| Nov 11, 2024 | 28.6× |
| Feb 13, 2025 | 27.2× |
| May 15, 2025 | 25.8× |
| Aug 15, 2025 | 23.7× |
| Nov 13, 2025 | 21.6× |
| Feb 17, 2026 | 23.6× |
| May 18, 2026 | 20.8× |
| Aug 18, 2026 | 21.7× |
| Nov 12, 2026 | 25.3× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $174, 4% above the current price; 56% of 25 analysts rate it a buy; earnings beat estimates in all of the last 4 quarters.
Buy or Strong Buy: 14 analysts (56%). Sell or Strong Sell: 0.
Over the past year the average of the analysts' latest price targets went from $169.89 to $173.67 (+2%), while PG went from $147.96 to $168.03 (+14%). In the past three months targets were raised 13 times and cut once. 4 upgrades and 3 downgrades over the year; the latest: Freedom Broker moved it to Buy from Hold on Oct 23, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Oct 26, 2026 | Barclays | Target raised | Equal-Weight | $165.00, was $152.00 |
| Oct 26, 2026 | Piper Sandler | Target raised | Neutral | $167.00, was $145.00 |
| Oct 23, 2026 | Freedom Broker | Upgrade | Buy, was Hold | $176.00 |
| Oct 23, 2026 | UBS | Target raised | Buy | $190.00, was $172.00 |
| Oct 23, 2026 | Citigroup | Target raised | Buy | $187.00, was $180.00 |
| Oct 23, 2026 | BNP Paribas | Target raised | Outperform | $189.00, was $177.00 |
| Oct 23, 2026 | JP Morgan | Target raised | Overweight | $180.00, was $162.00 |
| Oct 23, 2026 | Evercore ISI Group | Target raised | Outperform | $180.00, was $166.00 |
| Oct 23, 2026 | RBC Capital | Target raised | Outperform | $169.00, was $166.00 |
| Oct 23, 2026 | Wells Fargo | Target raised | Overweight | $180.00, was $164.00 |
| Oct 23, 2026 | TD Cowen | Target raised | Hold | $166.00, was $150.00 |
| Oct 23, 2026 | Morgan Stanley | Target raised | Overweight | $185.00, was $166.00 |
| Oct 20, 2026 | RBC Capital | Target kept | Outperform | $166.00 |
| Oct 14, 2026 | Citigroup | Target raised | Buy | $180.00, was $170.00 |
| Oct 6, 2026 | Evercore ISI Group | Upgrade | Outperform, was In-Line | $166.00, was $161.00 |
| Oct 6, 2026 | RBC Capital | Target cut | Outperform | $166.00, was $167.00 |
| Sep 30, 2026 | TD Cowen | Target kept | Hold | $150.00 |
| Aug 7, 2026 | Argus Research | Downgrade | Hold, was Buy | — |
| Jul 30, 2026 | HSBC | Downgrade | Hold, was Buy | $149.00, was $182.00 |
| Jul 30, 2026 | Citigroup | Target cut | Buy | $170.00, was $181.00 |
| Jul 21, 2026 | Barclays | Target raised | Equal-Weight | $152.00, was $146.00 |
| Jul 16, 2026 | JP Morgan | Target cut | Overweight | $162.00, was $164.00 |
| Jul 10, 2026 | B of A Securities | Target cut | Buy | $166.00, was $170.00 |
| Jun 11, 2026 | Bernstein | Began coverage | Market Perform | $156.00 |
| Apr 27, 2026 | UBS | Target raised | Buy | $172.00, was $166.00 |
| Apr 27, 2026 | TD Cowen | Target raised | Hold | $150.00, was $142.00 |
| Apr 27, 2026 | Wells Fargo | Target raised | Overweight | $164.00, was $158.00 |
| Apr 27, 2026 | Evercore ISI Group | Target cut | In-Line | $162.00, was $170.00 |
| Apr 17, 2026 | JP Morgan | Target cut | Overweight | $162.00, was $165.00 |
| Apr 14, 2026 | Barclays | Target cut | Equal-Weight | $146.00, was $155.00 |
| Apr 10, 2026 | B of A Securities | Target cut | Buy | $167.00, was $171.00 |
| Apr 8, 2026 | Wells Fargo | Target cut | Overweight | $158.00, was $177.00 |
| Apr 8, 2026 | Piper Sandler | Target cut | Neutral | $142.00, was $150.00 |
| Apr 7, 2026 | UBS | Target cut | Buy | $166.00, was $170.00 |
| Mar 30, 2026 | Deutsche Bank | Target cut | Hold | $162.00, was $171.00 |
| Jan 27, 2026 | TD Cowen | Downgrade | Hold, was Buy | $156.00, was $150.00 |
| Jan 23, 2026 | UBS | Target raised | Buy | $170.00, was $161.00 |
| Jan 23, 2026 | Wells Fargo | Target raised | Overweight | $165.00, was $158.00 |
| Jan 23, 2026 | JP Morgan | Upgrade | Overweight, was Neutral | $165.00, was $157.00 |
| Jan 14, 2026 | UBS | Target cut | Buy | $161.00, was $176.00 |
| Jan 8, 2026 | TD Cowen | Target cut | Buy | $150.00, was $168.00 |
| Jan 5, 2026 | Wells Fargo | Target cut | Overweight | $158.00, was $170.00 |
| Dec 18, 2025 | JP Morgan | Target cut | Neutral | $157.00, was $165.00 |
| Dec 17, 2025 | Jefferies | Upgrade | Buy, was Hold | $179.00, was $156.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $1.86 | $1.88 | +1.1% |
| Mar ’26 | $1.56 | $1.59 | +1.9% |
| Jun ’26 | $1.41 | $1.43 | +1.4% |
| Sep ’26 | $1.89 | $2.00 | +5.8% |
The day after each of these reports the stock moved +2.8% (Dec 2025, beat); +1.8% (Mar 2026, beat); −3.3% (Jun 2026, beat); +2.7% (Sep 2026, beat).
For the quarter ending Dec 2026 (The Procter & Gamble Company reports on Jan 21, 2027), analysts expect adjusted earnings of $1.81 a share, 3% less than the $1.88 of a year earlier, and revenue of $22.9B, up 3% on a year earlier. For the fiscal year ending Jun 2027, they expect revenue of $89.8B, up 3% on the year before.
Adjusted. Dec 2025: $1.88; range $1.71 to $1.89; 20 analysts
Dec 2025: $22.2B; range $22.6B to $23.1B; 16 analysts
The year to Jun 2026: $87.0B; range $89.1B to $90.8B; 19 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Jan 21, 2027 | EPS (adjusted) | $1.81 | $1.71 to $1.89 | 20 | $1.88 (Dec 2025) | −3% |
| Quarter ending Dec 2026, results Jan 21, 2027 | Revenue | $22.9B | $22.6B to $23.1B | 16 | $22.2B (Dec 2025) | +3% |
| Quarter ending Mar 2027 | EPS (adjusted) | $1.63 | $1.59 to $1.68 | 16 | $1.59 (Mar 2026) | +3% |
| Quarter ending Mar 2027 | Revenue | $21.7B | $21.4B to $22.0B | 12 | $21.2B (Mar 2026) | +2% |
| Year ending Jun 2027 | Revenue | $89.8B | $89.1B to $90.8B | 19 | $87.0B (year to Jun 2026) | +3% |
| Year ending Jun 2028 | Revenue | $92.6B | $91.3B to $93.9B | 18 | $89.8B (expected, year to Jun 2027) | +3% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $15.3B in free cash flow over the year, of which $15.3B went back to shareholders (dividends plus buybacks), leaving $30M in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $19.9B |
| Capex | −$4.6B |
| Free cash flow | $15.3B |
| Dividends | −$10.3B |
| Buybacks | −$5.0B |
| Cash retained | $30M |
For every $100 of market cap, the company generates about $3.9 in free cash flow a year.
For every $100 of market cap, you receive about $2.6 in dividends a year.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $3.9 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $4.3B | $2.3B | $1.0B |
| Mar 2024 | $3.3B | $2.3B | $987M |
| Jun 2024 | $5.0B | $2.4B | $1.5B |
| Sep 2024 | $3.3B | $2.4B | $1.9B |
| Dec 2024 | $3.9B | $2.4B | $2.5B |
| Mar 2025 | $2.8B | $2.4B | $1.4B |
| Jun 2025 | $4.0B | $2.6B | $700M |
| Sep 2025 | $4.2B | $2.5B | $1.2B |
| Dec 2025 | $3.8B | $2.5B | $2.3B |
| Mar 2026 | $3.0B | $2.5B | $625M |
| Jun 2026 | $4.1B | $2.6B | $875M |
| Sep 2026 | $4.4B | $2.6B | $1.2B |
The Procter & Gamble Company had 2.41B diluted shares in the quarter ended Sep 2026, 1.2% fewer than a year earlier, and 1.3% fewer each year on average since Mar 2020. It spent $5.0B on buybacks over the last four quarters. Over the last four quarters its earnings per share fell 3.1% and its net income fell 4.4%: fewer shares added about 1 point.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Mar 2020 | 2.61B |
| Sep 2020 | 2.63B |
| Dec 2020 | 2.62B |
| Mar 2021 | 2.59B |
| Sep 2021 | 2.56B |
| Dec 2021 | 2.54B |
| Mar 2022 | 2.53B |
| Sep 2022 | 2.50B |
| Dec 2022 | 2.48B |
| Mar 2023 | 2.47B |
| Sep 2023 | 2.48B |
| Dec 2023 | 2.47B |
| Mar 2024 | 2.47B |
| Sep 2024 | 2.47B |
| Dec 2024 | 2.46B |
| Mar 2025 | 2.45B |
| Sep 2025 | 2.44B |
| Dec 2025 | 2.42B |
| Mar 2026 | 2.42B |
| Sep 2026 | 2.41B |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 0.7, short-term debt coverage is tight; debt-to-equity 0.6, debt is moderate.
Assets that can be turned into cash soon are 0.7x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.6 of debt (leases not counted). The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $9.9B against debt of $34.1B. Lease obligations of $887M are not counted: they are rent owed, not money borrowed.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 5 members of Congress and 9 funds whose copy leaves PG out (not traded on the exchange): Fundsmith, Nan Shan Life Insurance, Fisher Asset Management, Swiss National Bank, Norges Bank, Mirae Asset Global Investments and 8 more.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 18 held PG at the end of their latest quarter (for most, Q2 2026). Over that quarter 6 added shares, 9 cut, 2 bought new and 1 held the same. The largest of them is Norges Bank, 31.83M shares worth $4.7B at Jun 30, 2026, 2.2% fewer than at Dec 31, 2025.
2 of them new holders
Over their latest quarter
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 31.83M | $4.7B | −718,608 | −2.2% | Aug 12, 2026 |
| Fisher Asset Management | Q3 2026 | 12.08M | $1.8B | +845,717 | +7.5% | Nov 6, 2026 |
| Swiss National Bank | Q3 2026 | 6.37M | $925M | −185,500 | −2.8% | Nov 12, 2026 |
| National Pension Service | Q3 2026 | 5.67M | $823M | +28,756 | +0.5% | Nov 12, 2026 |
| Fundsmith | Q2 2026 | 4.08M | $598M | −121,543 | −2.9% | Aug 14, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 3.76M | $552M | −610,281 | −14% | Aug 14, 2026 |
| Yacktman Asset Management | Q3 2026 | 1.98M | $287M | +13,977 | +0.7% | Nov 2, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 1.71M | $248M | +234,248 | +16% | Nov 3, 2026 |
| Korea Investment | Q2 2026 | 1.40M | $205M | −263,688 | −16% | Aug 12, 2026 |
| Baillie Gifford & | Q3 2026 | 782,911 | $114M | −36,598 | −4.5% | Nov 9, 2026 |
| Nomura Holdings | Q2 2026 | 355,024 | $52.1M | +306,537 | +632% | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 312,317 | $45.8M | +312,317 | New | Aug 14, 2026 |
| Nan Shan Life Insurance | Q2 2026 | 292,168 | $42.8M | +119,342 | +69% | Aug 14, 2026 |
| Bridgewater Associates | Q2 2026 | 137,724 | $20.2M | −20,182 | −13% | Aug 14, 2026 |
| Renaissance Technologies | Q3 2026 | 106,800 | $15.5M | +106,800 | New | Nov 12, 2026 |
| Dodge & Cox | Q2 2026 | 90,706 | $13.3M | −50 | −0.1% | Aug 13, 2026 |
| Gardner Russo & Quinn | Q3 2026 | 6,391 | $928K | −163 | −2.5% | Nov 12, 2026 |
| Harris Associates L P | Q2 2026 | 1,494 | $219K | 0 | 0.0% | Aug 14, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of PG at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.